Stonegate Capital Partners Initiates Coverage on GoHealth Inc. (GOCO)

Rhea-AI Summary

GoHealth Inc. (NASDAQ: GOCO) demonstrated robust performance in Q4 2024, with net revenues climbing 41% year-over-year to $389.1 million. The company's success was driven by a significant 67% increase in submissions, while achieving operational efficiencies with a 27% improvement in Direct Operating Cost per Submission to $501.

The Medicare-focused digital health marketplace provider reported a remarkable turnaround, posting a net income of $58.0 million, compared to a loss in the previous year. Additionally, the company's Adjusted EBITDA more than doubled to $117.8 million, reflecting successful strategic investments in technology and operational excellence.

Positive

• Net revenues increased 41% YoY to $389.1M
• Achieved net income of $58.0M, turning around from previous year's loss
• Adjusted EBITDA more than doubled to $117.8M
• Submissions grew 67% YoY
• Direct Operating Cost per Submission reduced by 27% to $501

Negative

• None.

News Market Reaction

+3.38%

1 alert

+3.38% News Effect

On the day this news was published, GOCO gained 3.38%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Dallas, Texas--(Newsfile Corp. - March 24, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners initiates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. delivered a strong fourth quarter in 2024, highlighted by substantial revenue growth and operational efficiencies. Net revenues surged 41% year-over-year to $389.1M, driven by a 67% increase in submissions. The Company posted net income of $58.0M, marking a substantial turnaround from the prior year's loss, while Adj. EBITDA more than doubled to $117.8M. This performance underscores GOCO's leadership in the Medicare-focused digital health marketplace, bolstered by strategic investments in technology and operational excellence. As the Company enters 2025, management remains focused on sustainable growth and expanding market share through innovation and disciplined execution.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

• Net revenues surged 41% y/y to $389.1M.
• Saw a 170% year-over-year increase in submissions.
• Direct Operating Cost per Submission improved by 27% year-over-year to $501.

Click image above to view full announcement.

---

About Stonegate

Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/245801

FAQ

What was GoHealth's (GOCO) revenue growth in Q4 2024?

GoHealth's net revenues grew 41% year-over-year to $389.1 million in Q4 2024.

How much did GoHealth (GOCO) improve its Direct Operating Cost per Submission in Q4 2024?

GOCO improved its Direct Operating Cost per Submission by 27% year-over-year to $501.

What was GoHealth's (GOCO) net income in Q4 2024?

GoHealth reported a net income of $58.0 million in Q4 2024.

How much did GoHealth's (GOCO) submissions increase in Q4 2024?

GoHealth experienced a 67% year-over-year increase in submissions during Q4 2024.

What was GoHealth's (GOCO) Adjusted EBITDA in Q4 2024?

GoHealth's Adjusted EBITDA more than doubled to $117.8 million in Q4 2024.